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Abstract
Background: Tuberculosis (TB) treatment loss to follow up (LTFU) plays an important contributory role to the
staggering TB epidemic in South Africa. Reasons for treatment interruption are poorly understood. Treatment
interruption appears to be the culmination of poor health literacy of patients and inadequate health education
provided by clinicians. We explored clinician and patient perspectives of the gaps in TB messaging that influence
TB treatment LTFU.
Methods: We conducted semi-structured in-depth interviews between January and May 2018 with a sample of 15
clinicians managing TB and 7 patients identified as LTFU in public clinics in the Free State Province, South Africa.
Thematic analysis using a mixed deductive/inductive thematic approach was used.
Results: Limited occupational opportunities, fear of disclosure and stigmatization all contributed to treatment LTFU.
Patients felt that the TB messaging received was inadequate. Many of the clinicians interviewed felt that improving
patient’s TB knowledge would reinforce adherence to treatment and thus focused on sharing information on
treatment completion, side effects and infection control. However, the inability of clinicians to establish rapport
with patients or to identify social support challenged TB treatment adherence by patients. Clinicians perceived this
as patients not following their instructions despite what they considered lengthy TB education. Having said this,
clinicians concurred that their medical management of TB lacked the psycho-social dimension to treat a social
disease of this magnitude.
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Conclusions: Limited occupational opportunities, fear of disclosure and stigmatization all contributed to treatment
LTFU. Clinicians concurred that poor patient understanding of TB and that biomedical management lacking a
psycho-social dimension further exacerbated the poor treatment outcome. TB remains a social disease, the
successful management of which hinges on patient-centred care.
Keywords: Tuberculosis TB, Adherence, Messaging, Loss to follow up, Knowledge, Health literacy, Patient-centered
care
Background
Tuberculosis (TB) remains the leading cause of death
from a single infectious agent globally, ranking higher
than HIV/AIDS (human immunodeficiency virus/ ac-
quired immunodeficiency syndrome), and despite treat-
ment being available [1]. In 2018, South Africa ranked
fourth on the list of high TB burden countries based on
absolute number of TB cases with an estimated 520 inci-
dent cases per 100,000 population [1]. The fragmented
South African health system is largely accountable for
the diagnostic delays, inconsistent guideline implementa-
tion and poor TB outcomes that mar the TB programme
[2]. The comprehensive cascade of care analysis con-
ducted by Naidoo et al on the 2013 programmatic data
revealed that 5% were unable able to access TB testing,
13% did not receive their TB diagnosis and 12% were
never initiated on treatment [3]. However, evidence sug-
gests that these ‘missed’ cases continue to engage with
the health system and the system fails to manage them
appropriately [3]. In 2016, South African data estimates
that 17%of patients initiating TB treatment failed to
complete their treatment; an attrition equivalent to 92,
761 individuals [3].
TB control efforts are persistently undermined by so-
cial, financial and clinical barriers to care [4]. TB treat-
ment adherence is vital in achieving disease cure in
individual patients and preventing disease spread within
the community [5]. The World Health Organization’s
(WHO) has declared the ongoing emergence and spread
of drug resistant TB a global crisis, emphasizing the ne-
cessity for TB patients to complete their course of TB
treatment [1]. Patients incur considerable out of pocket
expenses in accessing TB services despite TB diagnosis
and care services being offered free in South Africa; with
the poorest patients incurring highest relative costs [6].
Poor treatment adherence increases the length and se-
verity of illness and complicates disease transmission
and drug resistance; carrying negative economic conse-
quences for the patient, community and the health sys-
tem [7].
Studies exploring TB treatment completion generally
adopt a bio-medical approach, though TB has long been
considered a ‘social’ disease [8]. Socioeconomic and indi-
vidual circumstances including patients’ sense of feeling
better, occupational commitments, side effects, and mis-
information on treatment duration impact heavily on
treatment completion [9–14]. Health education is inte-
grated into services provided at primary health care
(PHC) level in South Africa [15]. However, inadequate
patient counselling on treatment expectations [16, 17]
and inconsistent implementation of the Directly Ob-
served Treatment, Short Course (DOTS) strategy [18,
19] continue to exacerbate TB treatment LTFU. Apart
from South Africa, similar findings of poor patient-
provider communication hindering TB treatment com-
pletion have been demonstrated as far afield as Eritrea,
Tanzania, Pakistan and Ethiopia; always with the discus-
sion prioritizing strengthened patient-provider trust and
treatment literacy [20–24].
The WHO End TB Strategy has endorsed a holistic
patient centred model of care, focused on patient rights
and welfare, to improve TB outcomes globally [25–27].
Disseminating accurate, evidence-based TB information
among patients and clinicians alike, is fundamental to
achieving this. Data from as far back as 1997 purported
that TB care in South Africa remained nurse-centred
with poor receptivity and confirmation by the patient
[28].
Despite the need to empower patients to actively man-
age their TB, current literature lacks feasible approaches
to accomplish this empowerment. This study allows for
exploration of the complex social, cultural and environ-
mental phenomena relating to TB treatment LTFU in




This study was conducted at three public health facilities
in the Mangaung District (Free State Province, South Af-
rica) that served high density, marginalised communities
with rife unemployment and poverty [29]. HIV preva-
lence and TB mortality were estimated at 11 and 9% re-
spectively in the in the district [29]. The incidence of
drug sensitive TB among those commenced on TB treat-
ment in the Free State Province (2017) was 429.8 per
100,000, compared with the national average of 378.6
per 100,000 [30]. Tuberculosis was the leading cause of
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death, irrespective of age or sex, in the Free State Prov-
ince [31] and HIV-positive TB mortality accounted for
73% of deaths among patients with TB in 2018 [1]. Fur-
ther, 94% of patients newly diagnosed with TB were ini-
tiated on TB treatment and 90% of those patients who
were TB/HIV co-infected were able to access anti-
retroviral therapy [29]. Patients documented as LTFU
regarding their TB treatment and clinicians that man-
aged patients with TB at these facilities were approached
to participate in the study.
Design
This exploratory qualitative study was conducted be-
tween January and May 2018 with purposive sampling
used to select patients. Three research assistants (RAs)
that conducted the in-depth interviews (IDIs) were Good
Clinical Practice (GCP) accredited, trained in qualitative
data collection, had previous interviewing experience
and fluent in the local languages (English, Sesotho, and
Setswana). During training, interviewers were assessed
and given feedback following direct observations on
their ability to collect data using the interview guides.
The investigators regularly reviewed the interviews and
provided frequent feedback to the research assistants.
Debriefing sessions were arranged to discuss experiences
of conducting interviews, interview content, how to im-
prove probing skills and address challenges.
The interviewers prior contact with the patients was
limited to arranging interviews. The interviewers had en-
gaged with the clinicians previously during quantitative
TB work conducted at the facilities. Participants were
provided with information on the qualitative component
of the study and the interviewer’s role during the inter-
view. The semi-structured interview questions allowed
for the successive coding process required for deductive/
inductive thematic analysis approach.
Data collection
Patients and clinicians that were willing to provide writ-
ten voluntary informed consent and agreed for the ses-
sion to be digitally recorded were interviewed. Separate
interview guides were developed for the patients
(Annexure 1) and clinicians (Annexure 2) that explored
access to health care, perceived quality of care, TB
knowledge and how treatment support impacted TB
treatment completion. The interviews were audio-
recorded and were between 30 to 90 min. Basic demo-
graphic information (e.g. age, level of education, distance
to clinic, and source of income, history of co-
morbidities) was collected from patients (Annexure 3:
Table 1). Information on position of employment and
years of experience was collected from clinicians
(Annexure 3: Table 2). The interviewers made field
notes after the interviews. It was the author’s assessment
that saturation was reached by revising the probes dur-
ing data collection.
Patients listed on electronic TB records from study fa-
cilities; aged ≥18 years and documented as LTFU (as per
the WHO treatment outcome definition [32]), were in-
vited to participate in the study. The sample varied by
age and gender. Patient contact information was re-
trieved from the clinical records. Initial attempts were
made to contact patients telephonically. Failing which, li-
aison with the local tracing team was undertaken to
trace patients using listed addresses. Adherence to
standard practise for LTFU tracing was ensured with
only the clinical staff of the facility, the contact tracing
team and members of the research team who were
tasked with locating LTFU patients having access to the
patient identity and contact information. Reports sub-
mitted contained anonymised data. From a total of 268
patients identified with the TB outcome of LTFU on the
ETR.net and EDR.web (electronic TB registers), we were
only able to retrieve 71 case files. Sixty-one (61) of these
case files contained invalid contact details and we were
thus only able to contact 10 patients for interviews. One
patient was unable to be interviewed as he had relocated
to another province and two had died. The remaining
seven patients identified for interviews were approached
either face-to-face or telephonically. Five patients chose
to be interviewed at their homes and two chose the facil-
ity. (Annexure 4). Patients who commuted to the facility
for the interview were reimbursed R150 ($10 US) in lieu
of travelling expenses. Inadequate collection of patient
contact information and treatment records impacts on
tracing and management of patients. Sinai et al. demon-
strated that it is commonplace for patients to move be-
tween facilities once they have commenced their TB
treatment [33]. Often these movements occur without
prior notice to the provider and rendering patient track-
ing difficult to trace [3, 34, 35]. Sinai et al. additionally
reflected on the data quality issues within the patients’
records, TB screening registers and case registers and
with routine laboratory data including incompleteness,
errors and discrepancies [33].
Clinical managers at each facility in collaboration with
the research team identified clinicians that could be
interviewed. Clinicians were currently employed at the
selected health facilities; and were part of the nursing
staff or doctors that were directly involved in TB care
and management. Clinicians were approached face-to-
face for participation and interviews were arranged at
their convenience. Interviews were conducted in private
areas within the facility.
Data analysis
Recorded interviews were transcribed verbatim and
translated to English where applicable by research
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assistants. Transcripts were checked for accuracy by the
research assistants. The transcripts were further
checked, and identifiers removed by two investigators
with medical and doctorate level qualifications. Manual
coding was used for data analysis. To validate the find-
ings, independent coding and theme identification was
conducted by the same investigators. A codebook was
developed that comprised a priori codes derived from
the original question guide. Emerging thematic codes
were developed during the thematic analysis and added
to the codebook as required. Concepts from different in-
terviews were pooled together and integrated into com-
mon themes. For reliability, four additional investigators
reviewed the codebook before themes were finalised
using the deductive/inductive thematic approach. The
themes are represented as direct quotes. The themes
were summarised by the authors as they were developed
during the analysis and the direct quotes by the partici-
pants were used to support the summary.
Ethics
Ethics approval for this study was obtained through the
Human Research Ethics Committee (University of the
Witwatersrand) [Ethics approval no: 170606] and the
Free State Department of Health [Ethics approval no.
FS_2017RP10_005]. Written consent was obtained from
all participants. The interview scripts were coded, and
personal identifying details were not collected.
Results
Baseline characteristics of patients interviewed showed a
male predominance (86%) with mean age of patients be-
ing 37 years (7.8 standard deviations [SD]). Patients trav-
elled on average 9.8 km to the attending facility (Table
1). A total of 15 clinicians with varying experience (two
Medical Doctors, one Operations Manager, nine Profes-
sional Nurses and three Enrolled Nurses), were recruited
for in-depth interviews. The average duration of employ-
ment for the clinicians was 17 years (2.7 SD).
Main theme 1: Patient level perspectives regarding
adherence to TB treatment
Most patients reported that they were given TB informa-
tion by clinicians during their clinical visits. However, it
appears that the information received by patients did
not translate into improved TB clinical outcomes as evi-
denced by the inability of this cohort of patients to
complete their TB treatment regimen. Often patients
demonstrated an understanding of the disease but the
social determinants of health at play within the commu-
nity, such as diminished educational and employment
prospects, had far reaching consequences that included
TB treatment LTFU, fear of disclosure and
stigmatization. Patients felt that the TB messaging
received was inadequate. The sub-themes derived from
the interviews drew attention to the impact of health lit-
eracy on TB treatment outcomes and suggested that the
rigid implementation of the current TB treatment guide-
lines stifled active patient involvement in their ongoing
treatment. Commonly reported reasons for LTFU in the
literature (including long queues, financial difficulty at-
tending clinic and unreliable transport) were inconsist-
ently reported in this study and were not considered for
the analysis.
Subtheme 1.1: Gaps in health literacy related to
information on TB treatment adherence
Most patients demonstrated adequate knowledge of the
TB screening procedures and TB symptoms. However,
patients did not seem to understand the TB treatment
process and importance of their roles and responsibil-
ities in achieving successful TB outcomes. Most patients
described the TB messaging received as focussed on the
importance of adhering to TB treatment for the ‘entire
duration of therapy’, despite potential side effects of the
TB medication. “Yes, they tell you that you have the TB
illness and tell you that if you take your treatment cor-
rectly, comply to your treatment you will be fine. They
make you feel good that you end up accepting the fact
that you really have TB” (#4). Patients did not seem suf-
ficiently prepared regarding the side effects that were ex-
perienced while on TB treatment. “Yes, they (referring to
clinicians) did explain to me but though they have ex-
plained something, when it happens to you it is not the
same as talking about it, when it is happening, it is you
who feels the side effects of the treatment so even when
they mention that, they do explain but when you experi-
ence it somewhere, that does not sit well.” (#5).
Importantly, patients seemed to lack knowledge on the
length of treatment, nor that the treatment would have
to be continued significantly past the point where the
patient felt a subjective improvement in health. One pa-
tient described his experience as follows: “She (referring
to clinician) did not tell me, she never told me [to stop]
but I decided to stop the treatment. She told me that I
will be finishing taking treatment on the 12th, they said I
should give another sputum to check if TB is still active
or what. When I went to the clinic, I produced sputum
and I was okay. I was okay, my body weight was back,
and it’s when she told me that you will be completing
your treatment” (#7).
Subtheme 1.2: Challenge to individual TB treatment plans
Some patient’s decision to discontinue treatment was in
response to unmet expectations from clinicians. One pa-
tient felt that the rigidity of clinicians in failing to re-
structure the management plan to accommodate their
requests resulted in them interrupting their treatment. “I
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was treated well but they could not when I explained to
them that I will go away for work for this long (one
month) and I am asking for treatment that can last for
the time I am away. They could not give me like that, the
way I was asking them, that is the only reason that made
me to end up defaulting now” (#5).
Some patients also felt that the clinicians were not lis-
tening to their concerns and expected them to adjust to
the TB medication. “I vomited when I took the pills for
the first time and I had a bit of diarrhoea. To overcome
these, I went back to the clinic and they gave me soft por-
ridge powder and told me that I will get used to the pills
and they will get used to my system or body” (#4).
Patients also felt that some of the existing systems at
the public health facility were not conducive to them
accessing TB treatment efficiently. “I am delayed some-
times, I go at five o’clock in the morning and come home
at six o’clock in the afternoon. They are inconveniencing
us. It is just the fact that when I visited the clinic due to
epilepsy, when am I supposed to go that other side [to get
TB treatment], they are delaying us, and I would just
leave it like that” (#1). Another perceived obstacle to pa-
tients not adhering to their TB treatment plans could be
the negative attitude of clinicians towards patients. “I
was not feeling okay and I was coughing while at work
and I lost weight and I was taking no TB treatment up
until the manager/white guy came to fetch us to come
back from there. I went to take my treatment after I came
home, and the nurse/sisters reprimanded me there” (#3).
“I didn’t like the way she treated me and I did not
allow her and looked at me , asked why did I have this
and this on my neck, we were quarrelling , both of us you
see …. I did not do anything, I just left” (#6).
Sub-theme 1.3: Motivators to adhering to TB treatment
It seems that patients could be willing to adhere to their
TB treatment if they are given the opportunity to be
constructively involved in their health management.
“Uh, I think what can be done in situations like
mine, where it is work related. I think if they can try
and do as I pleaded, they should understand our
complaints and our reasons because we are asking,
and we are willing to get treatment the way we are
asking. I think that is the solution that can be done”
(#5).
Patients also seemed to express a need for individual
centred counselling which could help them develop and
manage their personal TB treatment plan. “I suffered,
and I could not accept the news, but I eventually ac-
cepted because it was checked from the lab sir. I eventu-
ally accepted because I was counselled. They told me to
come for my treatment that is when I believed and ac-
cepted that I do have TB” (#4).
Main theme 2: Clinician level perspectives regarding
patient adherence to TB treatment
Many clinicians felt that improving the patient’s TB
knowledge would reinforce adherence to treatment and
thus focused on sharing information on treatment com-
pletion, side effects and infection control. However, the
inability of clinicians to establish rapport with patients
or to identify social support challenged TB treatment ad-
herence by patients. Clinicians perceived this as patients
not following their instructions despite what they con-
sidered lengthy TB education. Having said this, the clini-
cians concurred that their medical management of TB
lacked the socio-economic dimension to treat a social
disease of this magnitude.
“Ehm from the training side with clinicians, ehm
mainly its ehm, they emphasise on … as we also
know as clinicians that emphasis is mainly on them,
informing patients about taking their treatment on a
daily basis and the importance and when to take
treatment mainly. But training, its, it doesn’t, you
know the training that I have attended doesn’t really
emphasise on the socio-economic factors of our pa-
tient,” (#8).
The subthemes below highlight how the clinician’s in-
dividual interpretation of the national TB guidelines re-
sulted in significantly different key messages being
communicated to patients, how the fragmentation of the
health system leads to ongoing patient and clinician
frustration; and begins to outline the importance of
community support in addressing TB.
Subtheme 2.1: Lack of standardisation of communication
regarding TB therapy
Clinicians felt empowered from the ongoing TB module
training aligned to the National TB Guidelines and this
was reflected broadly in their understanding of the TB
transmission dynamics and their demonstrated compe-
tency in TB care provision. However, the ability to trans-
fer this information successfully to all TB patients was
possibly lacking. “I think we still have to work hard, very
hard for the patients to understand TB. They really don’t
understand it, so there are few that are really under-
standing very well but I still think we still have a lot of
work to do, to teach patients more about TB” (#19).
Some clinicians anecdotally correlated successful treat-
ment completion with the patient’s knowledge of TB, as
they believed this indicated that the patients were taking
their illness seriously. “If they do not know, obviously if
you don’t have the reason why you are doing something,
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obvious it’s not going to do it mos (local South African
term indicating an expression) neh but if you have know-
ledge that you are supposed to take your medication so
that you can be better, obviously you will take the medi-
cation correctly” (#3).
During the consultations, few clinicians discussed in-
formation on the complications of interrupting or stop-
ping treatment; or regarding the continuation of
treatment should patients transfer to other facilities.
When transfer letters were negotiated, there was no in-
dication that the clinicians reinforced the dangers of
stopping or discontinuing treatment. “… we do encour-
age them that when you know that you are going some-
where, come and get your transfer letters so that you can
get the continuation of your treatment” (#19).
Subtheme 2.2: Dealing with patient frustration and health
system inadequacies
A few clinicians felt that providing TB services at a sin-
gle focal point allowed experienced staff to effectively
relay information on TB transmission, therapy and ad-
herence. This interaction would create the opportunity
for patients to express their expectations of clinicians
and clinicians would in turn improve patient rapport
and establish a supportive, therapeutic relationship. Fa-
miliarity and consistency within the health service would
reassure the patient and strengthen the trust in the care
provided; potentially allowing for the disclosure of diffi-
culties. “I am like a parent to them, you are free to them,
you talk, you educate the person so that he can come
back again. When he is having problems though he will
not be taking treatment from you, he is able to approach
you to ask” (#12).
Some clinicians felt that the staff rotation hindered
rapport with the TB patients due to short rotation pe-
riods at the TB focal point. As such, clinicians were un-
able to gain comprehensive insight into the patients’
perspective and TB messaging could not be personalised
to the patients need. Maintaining permanent staff at the
TB focal point was described as a reason for reducing
treatment interruption at their facility. “No the thing is,
it is impossible, here at the clinic as we are rotating and
then the patients come across a lot of faces. There are
those who are dependent on that certain sister, you see …
he can’t be explaining himself a lot. Is it that when the
other one comes in, the patient is supposed to explain
himself again and that is taking him backwards” (#12).
The personal attitudes of staff, often perceived as
harsh and condescending by the patients, may have con-
tributed to the failure in establishing rapport with the
patient. Often, the inability of the clinician to develop
the patient-clinician relationship resulted in abrupt dis-
continuation of TB treatment without the opportunity of
an intervention by the clinician.
“Unfortunately, people want to be treated by happy
people, attitude. So an over worked person some-
times can you know show a bad attitude and that
can, maybe he is having good intention, but the pa-
tient receives it differently and next time doesn’t
want to come back to the clinic, so those are some of
the things that can make patients not to come”
(#19).
Discussion
This exploratory study highlighted the complex interplay
of patients’ beliefs, perceptions and health literacy re-
garding TB treatment adherence and how the perceived
ineffective health service delivery colluded to hinder TB
treatment completion. A prominent finding of this study
were the apparent gaps in communication emanating
from the patient and health service. These communica-
tion gaps undermine strengthening the patient-centred
approach.
Communication experts describe effective communi-
cation as a comprehendible, two-way process naming
‘participation’ and ‘dialogue’ as key elements [36]. Pa-
tient education is reinforced with communication and
social mobilization programmes that together with the
broader community, are essential for improving TB cure
rates and enhancing sustainability [36]. Most clinicians
believed that the TB messaging they delivered was com-
prehensive and effective and that patients were only par-
tially receptive to the information. There are several
dimensions to this statement that should be explored.
Firstly, the clinicians have all described educating their
patients. However, there appears to be evidence to the
contrary regarding the quality of information given by
clinicians to patients. Christian et al. explored the quality
of HIV and TB health care provision in the Western
Cape and its alignment to the national protocols. They
cited that only 43% of cases met the minimum threshold
for adequate case management and protocol deviations
could be attributed to poor training and knowledge, defi-
ciencies in monitoring and the lack of clinical govern-
ance [37]. They reported consistently poor information
sharing by the staff; and the importance of returning for
TB results was only discussed in a third of interactions.
In this study, health promotion talks at facilities ad-
dressed generic information on TB symptoms and infec-
tion control measures, encompassing how treatment
completion ensured better health and prevented resist-
ant disease, cough hygiene practices and early TB symp-
tom identification and side effect diagnosis and
management. There was no standardised guideline from
which this information was drawn, and the message var-
ied across clinicians and facilities. Consequently, there
was no objective measure of whether the patients had
been adequately informed about the disease or its
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management. The overall findings from the Western
Cape study suggested low effort in communicating in-
valuable information regarding untreated TB and the
need for treatment and acknowledged that the poor ad-
herence to the protocols were possibly resulting in the
disappointing TB outcomes [37].
Secondly, the reception of information by patients
warrants critical appraisal. In the best-case scenario,
knowledge leads to understanding of taking informed ac-
tion, but this does not necessarily lead to the action [38]
for a multitude of reasons. Reasons ranging from access,
loss of income, stigma, side effects and pill burden have
long been implicated [39, 40]. The health literacy of pa-
tients has relevance in this context where patients have
interrupted treatment based on subjective improvement
in health. Studies from Malawi and Zambia showed that
patients advised to refrain from beer, smoking and fre-
quent sex during their TB treatment, without proper ex-
planation of these restrictions, were likely to reconsider
their presentation for treatment [38, 41]. Patient’s prefer-
ence for a treatment facility was rarely discussed during
the consultation and negotiation of care was not facili-
tated. Thus, despite DOT supporters being on duty at
some facilities, the clinicians found that tracing of LTFU
patients was a futile exercise given the false addresses
provided by the patients. As a result, facilities were made
reliant on LTFU patients self-presenting, after not been
located by treatment supporters.
Finally, the insufficiencies of the patient-clinician rela-
tionship are brought into question. Patient counselling
remains a critical element in reducing LTFU [38] redu-
cing LTFU pointing to integrated behavioural counsel-
ling and TB care promoting adherence to treatment
protocols [41, 42]. Clinicians require knowledge of TB
disease and its management and excellent communica-
tions skills to ensure quality patient education and com-
munication [43, 44]. User-friendly and culturally
appropriate resources presented in local languages are a
potential approach. The use of simple, written informa-
tion, enhanced by visuals cues like pictograms, have
been shown to enhance comprehension and recall of in-
formation [45–47]. The use of a pictorial-based TB
booklet in primary health care clinics in the Eastern
Cape, South Africa was perceived as an invaluable tool
in patient education [48]. Illustrated information has
been shown to strengthen patient communication by the
provision of accurate information that promotes adher-
ence to guidelines and minimises guesswork [49].
Whether it is with the use of new resources or in day-to
day care, clinicians need adequate training in communi-
cation, particularly when the interaction is linked to
treatment adherence [50]. Emerging mHealth technolo-
gies could serve to bridge this patient-clinician commu-
nication gap and reduce LTFU [51, 52] through text
messaging for example [24, 53]. However, this strategy is
reliant on the access to mobile technology and the avail-
ability of current contact details which have proved du-
bious in this study. Arulchelva et al. conducted similar
work in India and encouraged the use of mass media,
such as playing health related videos on mobile phones,
in addition for personal communication [54].
Most TB patients designated LTFU cited the under-
lying inability to negotiate their treatment plans as the
reason for the interruption in care. It appears that the
needs of the clinician during the consultation, described
as efficiently relaying information on TB treatment and
adherence, were met. However, whether this information
appropriately addressed the patients concerns and ex-
pectations appears only in the context of case-finding in
the literature [55–60] and not on treatment outcomes in
South Africa and globally. Similar findings from a previ-
ous study demonstrated that despite standardised guide-
lines effectively contributing to health coverage; ignoring
the subjective biopsychosocial aspects of care particu-
larly in rigid health systems resulted in ‘dehumanising’
the care process [25].
Adopting the patient centered approach is acknowl-
edged to be directly beneficial to patients as it allows the
clinician to reach an understanding of the patient’s ex-
pectations, feelings and social context of the illness [61].
The clinician that assumes the role of expert but re-
mains an equal in the relationship is likely to achieve
better treatment outcomes. Discussion of management
plans with the patient will allow for their preferences to
be considered, discussed and incorporated; thereby
adapting care to suit the individualised needs of the
patient. More widely, the patient centred approach
focusses on empowering TB patients and their commu-
nities, social support programmes and enhanced com-
munication and partnership between community and
health sectors [62].
Strength and limitations
An important strength of this study is the study being
based in a high-density population, with a significant TB
disease burden. Further, the opinions of both the pa-
tients and clinicians were sought allowing for the explor-
ation of TB treatment adherence from differing
perspectives. This study explored the reasons for discon-
tinuing TB treatment by approaching those who had
stopped TB treatment. However, the absence of the
views of those who had successfully completed treat-
ment, for the purposes of meaningful comparison, may
be considered a limitation of this study. We were unable
to access all the patients that were LTFU as they had
moved away, provided incorrect contact details or the
data was missing. Their inclusion may have yielded add-
itional insights. Potentially, some of the responses
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obtained may have been limited given the sensitive na-
ture of TB and its association with HIV, which also car-
ries a significant burden of stigma and discrimination.
The study was limited to a single district in the Free
State Province, thus the findings cannot be extrapolated
to other settings.
Conclusions
This study reiterates the need for exploring the critical
socio-cultural interface between clinician and patients in
order to achieve improved TB outcomes rather than the
current dependence on biomedical interventions. Enhan-
cing communication and developing innovative strat-
egies to convey TB messaging to patients and the
community should remain a critical focus of the clin-
ician. Further research is warranted in developing early
warning systems in identifying those at risk of treatment
interruption and in developing and testing communica-
tion tools that actively promote treatment adherence.
Lastly, it is vitally important to acknowledge the crucial
role nurse clinicians play in TB management and con-
trol, thus ensuring they are suitably trained cannot be
over-emphasized. TB remains a social disease, the suc-
cessful management of which hinges on patient-centred
care.
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